BMS and RCUS Related Headlines

Go Back

Jun 3, 2026 08:01AM Arcus Biosciences partners with Bristol Myers Squibb on kidney cancer trial
Jun 3, 2026 08:00AM Arcus Biosciences Announces Clinical Trial Collaboration and Supply Agreement to Evaluate Casdatifan in Combination with PD‑L1/VEGF‑A Bispecific Immunomodulator to Treat Kidney Cancer

BMS and RCUS Related Press Releases

Go Back

Jun 3, 2026 08:00AM Arcus Biosciences Announces Clinical Trial Collaboration and Supply Agreement to Evaluate Casdatifan in Combination with PD‑L1/VEGF‑A Bispecific Immunomodulator to Treat Kidney Cancer

BMS and RCUS Related SEC Filings

Go Back